Introduction Diffuse midline gliomas (DMGs) harboring the H3 K27M mutation (now classified as H3 K27M-altered diffuse midline glioma) represent one of the most devastating diagnoses in neuro-oncology. These tumors, which arise in critical midline structures like the thalamus and brainstem (e.g., DIPG), predominantly affect children and young adults. Historically, they have been uniformly fatal, with radiation therapy offering only transient palliative benefit and chemotherapy

Antibiotics are widely used to treat bacterial infections (not viral!). They are wonder drugs that are basically a bacteria's kryptonite. But many people stop taking antibiotics as soon as they start feeling better. When the fever goes goes down, the throat feels better and the pain lets off, it might feel like the worst of the infection has passed. This might tempt many from completing the full prescribed course. While it may seem harmless (after all its only a pill or two r

Image credit: Freepik According to the World Health Organization, obesity is a chronic disease resulting from complex interactions of genetics, neurobiology, and environment. In the U.S. adult obesity rates have doubled in the past three decades from 19% in 1990 to more than 42% in 2022. Moreover, a new study estimates 47% of adults in the U.S. to be affected by obesity by 2035. Consequently, a search for a safe and effective treatment has been an ongoing pursuit. Semaglutide

You feel better after a few days of treatment and decide to stop the medicine. You cannot remember whether you already took today’s dose. You take an over-the-counter tablet along with your prescription medication without asking your doctor. These situations are more common than many people even realize. Medications play an essential role in treating illnesses, controlling chronic conditions, and improving quality of life. However, small mistakes in how medicines are taken ca

Ozempic, Wegovy, Moujaro, Zepbound…these medications have been all over the media as the latest trend in weight loss drugs, but did you know they were developed for another purpose? What are GLP-1 agonists? Glucagon-like peptide 1 (GLP-1) is a naturally occurring human hormone. When a person eats or drinks, the body responds by releasing GLP-1 from the small intestine. This triggers the pancreas to release insulin while suppressing the release of glucagon, slows gastric empty

Why the Same Chemotherapy Can Help One Patient and Harm Another? Introduction Chemotherapy remains a cornerstone of cancer treatment across many malignancies, yet patient responses vary dramatically. Two individuals receiving the same regimen can experience entirely different outcomes, ranging from excellent tumour control to severe, life-threatening toxicity. For decades, these differences were largely attributed to age, organ function, or chance. Pharmacogenomics has reveal

Introduction Statins have been around for decades, and are one of the most prescribed medicines worldwide. Prescription numbers climb every year, and yet many people still have reservations about taking them. This article explores their use, reputation, and why they are still considered vital in reducing the risk of heart disease.   What are statins? Statins are a group of medicines which help reduce levels of “bad” cholesterol, also known as low-density lipoproteins (LDL). C

What are these versatile treatments? Recent excitement around GLP-1 medications has brought about interest in health benefits outside of the intended weight control and blood glucose effects. Doctors and researchers have noticed positive effects on other health conditions like chronic kidney disease, even without weight loss. There are quite a few examples of drugs with benefits reaching beyond the initially studied or approved use, and many are still used in an "off-label"

Antibiotics Antibiotics are a group medication used to treat or prevent bacterial infections by killing bacteria or stopping them from multiplying. They are prescription drugs that are available as liquids, creams, injections, and pills. Major classes include Beta-lactams (penicillins, cephalosporins), Macrolides, Tetracyclines, Fluoroquinolones, Aminoglycosides, and Glycopeptides. It is important to note that antibiotics treat infections caused by bacteria, such as strep thr

In clinical medicine, it’s easy to assume that if two patients receive the same diagnosis and the same prescription, their outcomes should look similar. In reality, that’s rarely the case. Some patients respond immediately to treatment, while others see little benefit or experience unexpected side effects. While genetics and lifestyle are often cited as explanations, another factor is gaining attention for its quiet but also very significant role: the gut microbiome. The gut

Introduction Hypertrophic cardiomyopathy (HCM) stands as the most common inherited cardiac disease, fundamentally characterized by unexplained thickening of the heart muscle and hypercontractility. In patients with the obstructive subtype (oHCM), the hypertrophied muscle acts like a roadblock, impeding the ejection of blood from the left ventricle into the aorta (Left Ventricular Outflow Tract [LVOT] obstruction). This results in debilitating symptoms such as dyspnea, chest p

For most of us, antibiotics are a quick fix: a small pill that can chase away an infection in a matter of days. But not all antibiotics are created equal. Certain commonly prescribed drugs -- especially a group known as fluoroquinolones -- carry a lesser-known risk: they can damage tendons. From the Achilles to the shoulder, these injuries can appear during treatment or even weeks later, sometimes with sudden, intense pain or long-lasting weakness. Doctors have documented cas

Introdution Obesity and Type 2 Diabetes Mellitus (T2DM) have evolved into global health crises, contributing to millions of deaths annually and significantly reducing life expectancy. While lifestyle interventions like diet and exercise remain the first line of defense, long-term adherence is notoriously difficult, creating a desperate need for effective pharmacological solutions. Enter Retatrutide: a novel "triple receptor agonist" that is generating massive buzz in the medi

Introduciton Triple-negative breast cancer (TNBC) represents the subtype of breast cancer with the least favorable outcomes, largely due to its aggressive molecular features and a historic lack of effective targeted treatment options. However, the landscape of oncology is shifting with the rise of Antibody-Drug Conjugates (ADCs). Based on the concept of the "magic bullet" first proposed by Paul Ehrlich, ADCs are designed to selectively deliver cytotoxic chemotherapy directly

Introduction For decades, the field of hepatology faced a glaring therapeutic void. Metabolically-dysfunction-associated steatohepatitis (MASH), formerly and still widely known as Non-Alcoholic Steatohepatitis (NASH), affects millions globally, driving a rising tide of cirrhosis, liver failure, and hepatocellular carcinoma. Despite its prevalence, affecting an estimated 5.3% of the global adult population, it has earned a reputation as a "graveyard" for pharmaceutical develop

You've just had a check-up with your doctor and the decision was made to start you on a new medication. Or maybe you've been discharged from the hospital and have been given a whole LIST of new medications to take. All you want to do is go home. The instructions are on the bottle. You don't need to know anything else...right? WRONG! Your doctor or pharmacist should be telling you all the nitty-gritty details about your new medication. If not, make sure to ask these questions!

Introduction Small-cell lung cancer (SCLC) is one of the most aggressive and difficult-to-treat forms of cancer, characterized by rapid growth and early metastasis. For decades, patients who progressed after initial platinum-based chemotherapy faced poor prognoses and limited treatment options, often relying on older chemotherapy agents with modest efficacy and high toxicity. This landscape shifted significantly on November 19, 2025, when the U.S. Food and Drug Administration

Introduction Obesity is a chronic disease associated with reduced quality of life and increased mortality, yet effective treatment options remain logistically challenging for many patients. While Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized the management of obesity and Type 2 diabetes, they are predominantly peptide-based drugs administered via subcutaneous injection. The production complexities and administration discomfort associated with injec

By Vanessa Muller, PharmD Introduction When public-health rules shift, pharmacies often become the steady, familiar places people turn for timely guidance. Over the past several years, from COVID-19 surges to mpox outbreaks to shifting preventive-service coverage, communities have navigated rapid uncertainty. Through all of it, one quietly powerful tool has helped keep care accessible: State Standing Orders. Standing Orders are statewide clinical protocols that allow pharmaci

by Benjamin Levinson, MD Drug discovery is a long and complicated process that entails the search for, and development of, an agent (chemical or biological) that will offer treatment of a human malady. A drug company invests extensive time and resources into this search. As one professional has said, ‘We find a chemical or biological substance and then wrap in scientific data to treat a disease of interest.’ This process of discovery begins in the laboratory and only after a